Large-scale testing (Phase 3)Study completedNCT02603705
What this trial is testing
Safety and Tolerability of Egalet-002 in Patients With Moderate-to-Severe Chronic Noncancer Pain
Who this might be right for
Moderate-to-severe Chronic Noncancer Pain
Egalet Ltd 281